CNCE insider transactions
Concert Pharmaceuticals Inc. (CNCE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for CNCE
- SEC Form 4: Stuart Nancy sold $50,380 worth of shares (6,048 units at $8.33) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 262,596 units (withholding obligation)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Munsie Jeffrey A sold $31,375 worth of shares (3,762 units at $8.34) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 88,049 units to cover withholding tax4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Cassella James V sold $31,375 worth of shares (3,762 units at $8.34) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 173,061 units to satisfy withholding obligation4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Becker Marc A. sold $31,337 worth of shares (3,762 units at $8.33) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 123,863 units (for tax liability)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Stuart Nancy sold $110,220 worth of shares (13,200 units at $8.35) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 268,644 units (withholding tax)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Munsie Jeffrey A sold $70,917 worth of shares (8,493 units at $8.35) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 91,811 units (for withholding tax)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Cassella James V sold $84,385 worth of shares (10,106 units at $8.35) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 176,823 units (withholding tax)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Becker Marc A. sold $70,917 worth of shares (8,493 units at $8.35) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 127,625 units (for withholding tax)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Tung Roger D sold $66,898 worth of shares (9,240 units at $7.24) as part of a pre-agreed trading plan, decreasing direct ownership by 0.94% to 971,018 units (tax liability)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Stuart Nancy sold $20,974 worth of shares (2,893 units at $7.25) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 281,844 units (for withholding tax)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Munsie Jeffrey A sold $20,974 worth of shares (2,893 units at $7.25) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 100,304 units (tax liability)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Cassella James V sold $20,974 worth of shares (2,893 units at $7.25) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 186,929 units to satisfy withholding tax4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Becker Marc A. sold $20,974 worth of shares (2,893 units at $7.25) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 136,118 units to cover withholding tax4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Hutt Peter Barton exercised 3,539 shares at a strike of $2.88 and sold $21,553 worth of shares (3,539 units at $6.09)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Van Heek Christi was granted 16,400 shares, increasing direct ownership by 64% to 42,051 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Jaeger Wilfred E was granted 16,400 shares, increasing direct ownership by 320% to 21,525 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Hutt Peter Barton was granted 16,400 shares, increasing direct ownership by 125% to 29,488 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Hoeiland Jesper was granted 16,400 shares, increasing direct ownership by 320% to 21,525 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Auchincloss Thomas G was granted 16,400 shares, increasing direct ownership by 93% to 34,025 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Aldrich Richard was granted 16,400 shares, increasing direct ownership by 5% to 358,500 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Van Heek Christi bought $49,998 worth of shares (10,526 units at $4.75), increasing direct ownership by 70% to 25,651 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Auchincloss Thomas G bought $28,500 worth of shares (6,000 units at $4.75), increasing direct ownership by 52% to 17,625 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Aldrich Richard bought $999,998 worth of shares (210,526 units at $4.75)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Tung Roger D sold $41,653 worth of shares (13,480 units at $3.09) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 980,258 units (tax withholding)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Stuart Nancy sold $18,631 worth of shares (6,049 units at $3.08) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 284,737 units (tax withholding)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Munsie Jeffrey A sold $11,625 worth of shares (3,762 units at $3.09) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 103,197 units (for withholding tax)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Cassella James V sold $11,625 worth of shares (3,762 units at $3.09) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 189,822 units to cover withholding tax4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Becker Marc A. sold $11,587 worth of shares (3,762 units at $3.08) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 139,011 units (tax withholding)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Tung Roger D was granted 208,900 shares, increasing direct ownership by 27% to 993,738 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Stuart Nancy was granted 120,400 shares, increasing direct ownership by 71% to 290,786 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Munsie Jeffrey A was granted 63,700 shares, increasing direct ownership by 147% to 106,959 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Becker Marc A. was granted 81,600 shares, increasing direct ownership by 133% to 142,773 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Cassella James V was granted 110,500 shares, increasing direct ownership by 133% to 193,584 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Tung Roger D gifted 14,500 shares and sold $28,552 worth of shares (9,240 units at $3.09) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 784,838 units to cover withholding tax4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Stuart Nancy sold $9,232 worth of shares (2,894 units at $3.19) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 170,386 units (for withholding tax)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Munsie Jeffrey A sold $9,261 worth of shares (2,894 units at $3.20) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 43,259 units (withholding obligation)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Cassella James V sold $9,232 worth of shares (2,894 units at $3.19) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 83,084 units to cover taxes4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Becker Marc A. sold $9,261 worth of shares (2,894 units at $3.20) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 61,173 units (tax liability)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Tung Roger D exercised 6,700 shares at a strike of $3.50 and sold $24,254 worth of shares (6,700 units at $3.62) as part of a pre-agreed trading plan4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Becker Marc A. sold $23,957 worth of Common Stock (7,304 units at $3.28), decreasing direct ownership by 10% to 64,067 units (for withholding tax)4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Cassella James V sold $26,522 worth of Common Stock (8,086 units at $3.28), decreasing direct ownership by 9% to 85,978 units to cover withholding tax4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: van Heek Christi was granted 5,125 units of Common Stock, increasing direct ownership by 51% to 15,125 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: JAEGER WILFRED E was granted 5,125 units of Common Stock4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: HUTT PETER BARTON was granted 5,125 units of Common Stock, increasing direct ownership by 64% to 13,088 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Hoeiland Jesper was granted 5,125 units of Common Stock4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Barrett Ronald W was granted 5,125 units of Common Stock4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Auchincloss Thomas G was granted 5,125 units of Common Stock, increasing direct ownership by 79% to 11,625 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: ALDRICH RICHARD was granted 5,125 units of Common Stock, increasing direct ownership by 2% to 342,100 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: D Roger Tung sold $97,056 worth of Common Stock (13,480 units at $7.20), decreasing ownership by 2% to 808,578 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: Nancy Stuart sold $44,279 worth of Common Stock (6,049 units at $7.32), decreasing ownership by 3% to 173,280 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: A Jeffrey Munsie sold $27,545 worth of Common Stock (3,763 units at $7.32), decreasing ownership by 8% to 46,153 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: V James Cassella sold $27,545 worth of Common Stock (3,763 units at $7.32), decreasing ownership by 4% to 94,064 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)
- SEC Form 4: A. Marc Becker sold $27,545 worth of Common Stock (3,763 units at $7.32), decreasing ownership by 5% to 71,371 units4 - CONCERT PHARMACEUTICALS, INC. (0001367920) (Issuer)